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Progesterone is one of the most important hormones of the steroidal pregnane se-
ries, secreted by corpus luteum and by placenta, which can be regarded as a hormonal
balancer, particularly of estrogens. It also helps to create a balance of all other steroids
and has intrinsic calming and diuretic properties. It is important in women and its im-
portance in men for the maintenance of prostate health is appreciated. Moreover, pro-
gesterone has a neuroprotective effect (1, 2). Thus, due to the importance of progestero-
nes to the human body and in continuation of our previous work on heterocyclic
synthesis (3–5), we would like to report here on the formation and characterization of
new promising steroidal heterocyclic derivatives derived from progesterone. Detection
of many emerging chemicals of concern, including antimicrobials and steroid hormones,
in the environment was increased in the past decade with the advancement of analytical
techniques. All compounds produced in this work are novel and their synthetic path-
ways are also novel. Therefore, the in vitro antimicrobial activity of the new steroidal de-
rivatives should be tested against Gram positive and negative bacteria, and fungi.
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The aim of this work was to synthesize steroidal hetero-
cycles and to elucidate the potential role of these com-
pounds as antimicrobial agents. The synthesis of steroi-
dal heterocycles containing the pyrazole, isoxazole, thia-
zole, pyrane, pyridine, pyridazine, or benzopyrane ring
attached to the pregnene nucleus is reported. Progestero-
ne (1) reacts with dimethyl formamide dimethyl acetal to
form enamine 2. Heterocyclization of 2 with hydrazines,
hydroxylamine, glycine, ethyl acetoacetate or cyanomet-
hylene afforded novel steroidal heterocyclic derivatives.
The in vitro antimicrobial evaluation showed that all
synthesized compounds show activity against the used
strains of Gram positive bacteria and fungi.
Keywords: progesterone, enamine, pyrazole, pyrane, anti-
microbial
* Correspondence, e-mail: raafat-mohareb@yahoo.com
EXPERIMENTAL
Synthetic methods, analytical and spectral data
Starting steroids were purchased from Sigma Company (Germany). Appropriate
precautions in handling moisture sensitive compounds were undertaken. Melting points
were determined on an electrothermal apparatus (Büchi 535, Switzerland) in an open ca-
pillary tube and are uncorrected. Elemental analyses were performed on a Yanaco CHN
Corder elemental analyzer (Japan). IR spectra (n, cm–1) were recorded in KBr pellets on a
PA-9721 IR spectrophotometer (Shimadzu, Japan). 1H NMR spectra were obtained on a
Jeol 300 MHz (Japan) spectrometer in DMSO-d6 as solvent, using TMS as internal refer-
ence and chemical shifts (d) are expressed in ppm. Mass spectra were recorded on Kra-
tos (75 eV) MS equipment (Germany).
For the nomenclature of steroid derivatives, we used the definitive rules for the no-
menclature of steroid published by the Joint Commission on the Biochemical Nomencla-
ture (JCBN) of IUPAC (6, 7).
Compound 2 was synthesized by reacting progesterone with dimethylformamide
dimethylacetal in refluxing xylene solution according to the literature procedure (8).
Synthetic pathways are presented in Schemes 1, 2, 3 and 4, and physicochemical and
spectral data for the synthesized compounds are given in Tables I and II.
Synthesis of 17-(pyrazol-3-yl)androst-4-en-3-one (3a) and 17-(1-phenylpyrazol-3-yl)androst-4-
-en–3-one (3b)
General procedure. – To a solution of compound 2 (0.66 g, 0.002 mol) in absolute etha-
nol (30 mL), either hydrazine hydrate (0.1 g, 0.002 mol) or phenylhydrazine (0.2 g, 0.002
mol) was added. The reaction mixture, in each case, was heated under reflux for 5 h,
then left to cool at room temperature and poured into ice/water mixture. The formed so-
lid product collected by filtration was dried and crystallized to give either 3a (crystal-
lized from ethanol) or 3b (crystallized from 1,4-dioxane).
Synthesis of 17-(isoxazol-6-yl)androst-4-en–3-one (4)
To a solution of compound 2 (0.66 g, 0.002 mol) in absolute ethanol (30 mL), contai-
ning sodium acetate (0.16 g, 0.002 mol), an equivalent amount of hydroxylamine hydro-
chloride (0.13 g, 0.002 mol) in water (5 mL) was added. The reaction mixture was boiled
under reflux for 3 h then left to cool to 20 °C and poured over ice/water mixture. The
formed solid product was collected by filtration and crystallized from 1,4-dioxane.
Synthesis of 17-(2-amino-3-cyanopyran-6-yl)androst-4-en–3-one (6a)
Malononitrile (0.13 g, 0.002 mol) was added to a suspension of compound 2 (0.66,
0.002 mol) in sodium ethoxide (0.01mol) prepared by dissolving sodium metal (0.23 g,
0.01 mol) in absolute ethanol (5 mL). The reaction mixture was heated under reflux for
5 h, then left to cool at room temperature, poured into ice/water mixture and neutrali-
zed with dilute hydrochloric acid. The solid product 6a, which was formed through the
formation of the non isolable intermediate 5a, was collected by filtration, dried and crys-
tallized from ethanol.
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Synthesis of 17-(2-hydroxy-3-cyanopyran-6-yl)androst-4-en–3-one (6b)
To a solution of compound 2 (0.66, 0.002 mol) in ethanol (30 mL), containing a cata-
lytic amount of triethylamine (0.5 mL), an equivalent amount of ethyl cyanoacetate (0.23 g,
0.002 mol) was added. The reaction mixture was heated under reflux for 5 h; after cool-
ing at room temperature, it was poured into ice/water mixture and neutralized with di-
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Table II. Spectral data of newly synthesized products
Compd.
No.
IR (n cm–1) 1H NMR (d, ppm) (DMSO-d6) MS (M+)
3a 3300 (NH), 2980, 2860
(CH3, CH2), 1715 (C=O),
1659(C=N), 1576 (C=C)
0.75 (s, 3H, 18-CH3), 0.92 (s, 3H, 19-CH3),
4.97 (s, 1H, C4-H), 6.14 (d, 1H, pyrazole,
H-4), 6.22 (d, 1H, pyrazole, H-5), 9.11 (s,
1H, NH, D2O-exchangeable)
338
3b 3050 (CH-aromatic), 2980,
2863 (CH3, CH2), 1715
(C=O), 1650 (C=N), 1590
(C=C)
0.75 (s, 3H, 18-CH3), 0.92 (s, 3H, 19-CH3),
4.82 (s, 1H, C4-H), 6.19 (d, 1H, pyrazole,
H-4), 6.34 (d, 1H, pyrazole H-5), 7.31–7.56
(m, 5H, C6H5)
414
4 2987, 2855 (CH3, CH2),
1718 (C=O), 1650 (C=N),
1580 (C=C)
0.72 (s, 3H, 18-CH3), 0.89 (s, 3H, 19–CH3),
4.70 (s, 1H, C4-H), 4.83 (d, 1H, isoxazole,
H-4), 5.23 (d, 1H, isoxazole, H-5)
339
6a 3320 (NH2), 2980, 2860
(CH3, CH2), 2225, (CN),
1710 (C=O), 1580 (C=C)
0.88 (s, 3H, 18-CH3), 1.05 (s, 3H, 19-CH3),
4.72 (s, 1H, C4-H), 6.33 (s, 1H, NH2, D2O
exchangeable), 7.03 (d, 1H, pyrane, H-4),
7.12 (d, 1H, pyrane, H-5)
392
6b 3400 (OH), 2982, 2820
(CH3, CH2), 1715 (C=O),
1590 (C=C)
0.83 (s,3H, 18-CH3), 1.07 (s, 3H, 19-CH3),
4.76 (s, 1H, C4-H), 7.03 (d, 1H, pyrane,
H-4), 7.12 (d, 1H, pyrane, H-5), 9.57 (s,
1H, OH, D2O exchangeable)
393
7 2980, 2863 (CH3, CH2),
1735, 1722, 1710 (3C=O),
1590 (C=C)
0.83 (s, 3H, 18-CH3), 1.03 (s, 3H, 19-CH3),
1.32 (t, 3H, ester CH3), 2.34 (s, 1H,
COCH3), 4.22 (q, 2 H, ester CH2), 4.82 (s,
1H, C4-H), 4.95 (d, 1H, CH), 5.23 (d, 1H,
CH). 4.95 (d, 1H, CH), 5.23 (d, 1H, CH)
481
9 3300 (OH), 2980, 2863
(CH3, CH2), 1725, 1708
(2C=O), 1590 (C=C)
0.79 (s, 3H, 18-CH3), 0.95 (s, 3H, 19-CH3),
2.23 (s, 3H, COCH3), 6.91 (d, 1H, pyran,
H-4), 7.02 (d, 1H, pyran, H-5), 9.57 (s, 1H,
OH, D2O-exchangeable)
410
11 2980, 2860 (CH3, CH2),
2225 (CN), 1710 (C=O),
1580 (C=C)
0.78 (s, 3H, 18-CH3), 0.95 (s, 3H, 19-CH3),
4.70 (s, 1H, C4-H), 1.25, 1.32 (2s, 6H, 2
CH3), 2.11 (s, 1H, CH2), 5.93 (d, 1H, pyra-
dizine, CH), 6.03 (d, 1H, pyradizine, CH)
389
13 3334 (NH), 2980, 2860
(CH3, CH2), 1715 (C=O),
1576 (C=C)
0.75 (s, 3H, 18-CH3), 0.92 (s, 3H, 19-CH3),
4.97 (s, 1H, C4-H), 5.23 (m, 2H, pyrol,
H-2, H-3), 8.14 (s, 1H, pyrol, CH), 9.11 (s,
1H, NH, D2O – exchangeable)
337
14 3360 (NH), 2980, 2855
(CH3, CH2), 2225 (CN),
1718, 1715 (2C=O), 1630
(C=N), 1580 (C=C)
0.78 (s, 3H, 18-CH3), 0.95 (s, 3H, 19-CH3),
1.15 (s, 3H, 21-CH3), 2.11 (s, 2H, CH2),
4.83 (s, 1H, C4-H), 9.55 (s, 1H, NH, D2O
exchangeable)
395
lute hydrochloric acid. The formed solid product of 6b, which was formed through the
intermediate formation of the non isolable 5b, was filtered off, dried, and crystallized
from ethanol.
Synthesis of 21-(dimethylaminoacryloyl)-20-(ethylacetoacetato)pregn-4-en-3-one (7)
To a solution of compound 2 (0.66 g, 0.002 mol) in ethanol containing a catalytic
amount of ammonium acetate (0.1 g), an equivalent amount of ethyl acetoacetate (0.23 g,
0.002 mol) was added. The reaction mixture was heated under reflux for 4 h, then left to
cool at room temperature and poured into ice/water mixture. The formed solid product
was filtered off, dried and crystallized from 1,4-dioxane.
Synthesis of 17-(2-hydroxy-3-acetylpyran-6-yl)androst-4-en–3-one (9)
To a solution of 2 (0.66 g, 0.002 mol) in toluene (30 mL), ethyl acetoacetate (0.23 g,
0.002 mol) was added. The reaction mixture was heated under reflux for 5 h and then
the reaction mixture was concentrated under vacuum. The solid product 9, was formed
through the intermediate formation of the non isolable 8; it was dried and crystallized
from 1,4-dioxane.
Synthesis of 17-(3-cyanomethylpyridazin-6-yl)androst-4-en-3-one (11)
To a solution of compound 2 (0.66 g, 0.002 mol) in 1,4-dioxane (30 mL), an equiva-
lent amount of freshly prepared cyanoacetic acid hydrazide (0.19 g, 0.002 mol) prepared
by the addition of an equivalent amount of hydrazine hydrate to ethyl cyanoacetate un-
der stirring at room temperature was added; the reaction mixture was heated under ref-
lux for 6 h and then concentrated under vacuum. The solid product of 11, which was for-
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15 3320 (NH), 3030 (CH-aro-
matic), 2982, 2868 (CH3,
CH2), 2225 (CN), 1730,
1710(2C=O), 1640 (C=N),
1590 (C=C)
0.75 (s, 3H, 18-CH3), 0.97(s, 3H, 19-CH3),
1.10 (s, 3H, 21-CH3), 4.73 (s, 1H, C4-H), 5
H, C6H5), 8.51 (s, 1H, NH, D2O exchange-
able)
483
17 3435 (NH2), 2982, 2868
(CH3, CH2), 2220 (CN),
1730, 1718, 1710 (3C=O),
1640 (C=N), 1590 (C=C)
0.75 (s, 3H, 18-CH3), 0.97 (s, 3H, 19-CH3),
1.10 (s, 3H, 21-CH3), 4.31 (s, 2H, pyridine,
H-5), 4.91 (s, 1H, C4-H), 6.33 (s, 2H, NH2,
D2O exchangeable)
462
18 2980, 2860 (CH3, CH2),
1725, 1710 (2C=O), 1640
(C=N), 1580 (C=C)
0.78 (s, 3H, 18-CH3), 0.95(s, 3H, 19-CH3),
1.05 (s, 3H, 21-CH3), 1.21, 1.34 (2s, 6H,
2CH3), 4.70 (s, 1H, C4-H), 6.28, 6.43 (2s,
2H, pyridine, H-3, pyridine H-5)
434
19 3325 (NH), 2980, 2860
(CH3, CH2), 1718, 1710,
1695 (3C=O), 1640 (C=N)
0.78 (s, 3H, 18-CH3), 0.95 (s, 3H, 19-CH3),
4.93 (s, 2H, CH2), 5.72(s, 2H, thiazole,
H-5), 8.25 (s, 1H, NH, D2O exchangeable)
469
20 3325 (NH), 3050 (CH aro-
matic), 2980, 2855 CH3,
CH2), 1730, 1710, 1690 (3
C=O), 1630 (C=N), 1578
(C=C)
0.78 (s, 3H, 18-CH3), 0.95 (s, 3H, 19-CH3),
1.05 (s, 3H, 21-CH3), 4.67 (s, 1H, C4-H),
6.99 (s, 1H, coumarin H-4), 7.32-7.55 (m, 4
H, C6H4), 11.2 (s, 1H, NH, D2O exchange-
able)
500
med via the intermediate formation of the non isolable 10, was filtered off, dried and
crystallized from ethanol.
Synthesis of 17-(pyrol-3-yl)androst-4-en-3-one (13)
To a solution of compound 2 (0.66 g, 0.002 mol) in acetic anhydride (30 mL), an
equivalent amount of glycine (0.15 g, 0.002 mol) was added, the reaction mixture was
heated under reflux for 3 h, and then concentrated under vacuum. The solid product of
13, which was formed via the intermediate formation of the non isolable 12, was filtered
off, dried and crystallized from ethanol.
Synthesis of 20-(cyanoacetylhydrazono)pregn-4-en-3-one (14)
A dry mixture of progesterone 1 (1.57 g, 0.005 mol) and freshly prepared cyanoacetic
acid hydrazide (0.49 g, 0.005 mol) was heated in an oil bath at 130 °C for 1 h and then
acetic acid (5 mL) was added. The solid product formed upon cooling at room tempera-
ture was triturated with ethanol, collected by filtration and crystallized from 1,4-dioxane.
Synthesis of 20-(1-phenyl-2-cyanopropenoylhydrazono)pregn-4-en-3-one (15)
To a solution of 14 (0.79 g, 0.002 mol) in absolute ethanol (30 mL) containing a cata-
lytic amount of pyridine (0.5 mL), benzaldehyde (0.21 g, 0.002 mol) was added. The re-
action mixture was heated under reflux for 4 h and then cooled at room temperature,
poured over ice/water mixture and neutralized with dilute hydrochloric acid. The for-
med solid product was filtered off, dried and crystallized from methanol.
Synthesis of 20-hydrazono-N-(4-amino-3-cyano-2,6-dioxopyridin-1-yl)pregn-4-en-3-one (17)
To a solution of compound 14 (0.79 g, 0.002 mol) in ethanol containing a catalytic
amount of pyridine (0.5 mL), an equivalent amount of ethyl cyanoacetate (0.22 g, 0.002
mol) was added. The reaction mixture was heated under reflux for 4 h, then left to cool
at room temperature, poured over ice/water mixture and neutralized with dilute hydro-
chloric acid. The formed solid product of 17, which was formed via the intermediate for-
mation of the non isolable 16, was filtered off, dried and crystallized from methanol.
Synthesis of 20-hydrazono-N-(4,6-dimethyl-2-oxopyridin-1-yl)pregn-4-en-3-one (18)
To a solution of 14 (0.73 g, 0.002 mol) in acetic anhydride (30 mL), an equivalent
amount of acetyl acetone (0.2 g, 0.002 mol) was added. The reaction mixture was heated
under reflux for 3 h and then concentrated under vacuum; the solid product so formed
was filtered off, dried and crystallized from ethanol.
Synthesis of 20-(4-oxothiazol-2-acetylhydrazonyl-2-yl)pregn-4-en-3-one (19)
To a solution of compound 14 (0.79 g, 0.002 mol) in ethanol containing a catalytic
amount of pyridine (0.5 ml), an equivalent amount of thioglycolic acid (0.18 mL, 0.002
mol) was added. The reaction mixture was heated under reflux for 5 h then left to cool at
room temperature, poured over ice/water mixture and neutralized with dilute hydroc-
hloric acid. The formed solid product was filtered off, dried and crystallized from ethanol.
34
R. M. Mohareb and H. Y. Hana: Synthesis of progesterone heterocyclic derivatives of potential antimicrobial activity, Acta Pharm. 58
(2008) 29–42.
Synthesis of 20-(coumarin-3-carbohydrazonyl)pregn-4-en-3-one (20)
To a solution of 14 (0.79 g, 0.002 mol) in dimethylformamide (30 mL) containing a
catalytic amount of piperidine (0.5 mL), salicylaldehyde (0.002 g, 0.002 mol) was added,
the reaction mixture was heated under refluxal for 5 h, cooled at room temperature, pou-
red over ice/water mixture and neutralized with dilute hydrochloric acid. The formed
solid product was filtered off, dried and crystallized from methanol.
Analytical and spectral data of all products are in agreement with the proposed
structure.
Antimicrobial activity
The in vitro antimicrobial activity of the structurally promising steroidal hetero-
cyclic derivatives 2, 3a,b, 6b, 7, 9, 11, 13, 15, 14, 17, 18 and 20 against two strains of Gram
positive bacteria (Bacillus subtilis CECT 498 and Bacillus cereus CECT 148), two strains of
Gram negative bacteria (Escherichia coli ECT 101 and Pseudomonas aeruginosa) and Candi-
da albicans CECT 1394 as a representative species of fungi was investigated. The newly
synthesized products were dissolved in aqueous ethanol to give a logarithmic series of
concentrations from 2 to 256 mg L–1 upon tenfold dilution with the growth medium and
spore suspension of the test fungi. The toxicity of compounds was determined via pipet-
te additions into the wells of multi-well slides, followed by 25 L of culture medium.
The inoculated slides were then incubated at 25 oC until short germ tubes appeared; ap-
proximately 50 m length (at 0 h) was measured. Five-L volumes of the prepared com-
pound test solutions were added to the inoculated wells, one control well on each slide
being treated with solvent only. The slides were then returned to the incubator until
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Table III. Antimicrobial activities of tested compounds
Compd.
MIC (g mL–1) (zone of inhibition, mm)
E. coli B. cereus B. subtilis C. albicans
2 12.50 (6) 20.52 (8) 6.25 (4) 8.65 (4)
3a – 6.25 (15) 20.01 (8) 30.23 (6)
3b – 12.32 (3) 16.32 (8) 14.40 (4)
6b – 12.30 (4) 4.22 (6) 12.55 (12)
7 – 25.36 (8) 23.63 (6) 26.12 (3)
9 – 20.15 (4) 23.16 (9) 100.00 (5)
11 16.64 0.06 (2) 6.33 (5) 50.17 (11)
13 – 18.32 (5) 6.22 (2) 0.40 (10)
15 10.46 (4) 8.66 (6) 25.33 (5) 12.22 (8)
17 – 6.05 (6) 12.42 (2) 4.55 (10)
19 – 0.05 (9) 3.13 (10) 0.61 (6)
20 – 12.34 (7) 6.13 (4) 0.40 (5)
Ampicillin 6.25 3.13 12.50 (10)
–
Cycloheximide – – – 12.50 (6)
germ tubes (400  50 m) long were visible in the control wells. Further growth was ar-
rested by the addition of lactophenol aniline blue to each of the wells. The minimal inhi-
bitory concentration (MIC, in g mL–1) was determined using an adaptation of the agar
streak dilution method based on radial diffusion (9, 10). Under the same conditions, am-
picillin (antibacterial) and cycloheximide (antifungal) were used as standards. MIC was
considered to be the lowest concentration of the tested compound (in dimethylformami-
de) that inhibits the growth of bacteria or fungi in the plate (Table III). Diameters of the
inhibition zones corresponding to MICs are also presented in Table III.
RESULTS AND DISCUSSION
In this work, the reaction of progesterone (1) with dimethyl formamide dimethyl-
acetal was studied. The reaction took place in xylene to give the enamine derivative 2 (8)
(Scheme 1).
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The heterocyclization of compound 2 with different chemical reagents was studied
with the aim of forming steroidal heterocyclic compounds with potential biological acti-
vities. Thus, compound 2 reacted with either hydrazine hydrate or phenylhydrazine to
give the pyrazolylandrostenone derivatives 3a and 3b, respectively, and the reaction of
compound 2 with hydroxylamine hydrochloride gave the isoxazolyandrostenone deriva-
tive 4. The 1H NMR of the latter product showed the presence of two doublets at d 4.83
and 5.23 ppm for the isoxazole protons at C-4 and C-5, respectively. The reaction of com-
pound 3 with either malononitrile or ethyl cyanoacetate gave the corresponding amino
pyranylandrostenone derivatives 6a,b. Formation of the latter product took place through
the intermediate formation of 5a,b (Scheme 1).
The reaction of compound 2 with ethyl acetoacetate in acetic acid afforded the
Knoevenagel condensation product 7. On the other hand, carrying the same reaction in
refluxing toluene gave the 3-acetyl-2-hydroxy pyranylandrostenone derivative 9. The re-
action took place through the intermediate formation of 8 (Scheme 2). The reaction of
compound 2 with cyanoacetylhydrazone in 1,4-dioxane gave pyridazinylandrostenone
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derivative 11 via the intermediate formation of 10 (Scheme 3). Thus, IR spectrum of com-
pound 11 showed the presence of one CN group streching at n 2225 cm–1. Moreover, the
1H NMR spectrum showed the presence of two singlets at d 0.78 and 0.95 ppm corres-
ponding to two CH3 groups, a singlet at d 2.11 ppm for the CH2 group, a singlet at d 4.70
ppm for C4-H and two doublets at d 5.93 and 6.03 ppm corresponding to the pyridazine
H-4 and H-5.
Compound 2 showed interesting reactivity when reacting with amino acids. Thus,
with glycine in acetic anhydride it gave the pyrolylandrostenone derivative 13. Forma-
tion of 13 can be explained in terms of the first condensation of the glycine CH2 group
with C=O group at C-20 of compound 2 to afford the intermediate 12 followed by cycli-
zation and decarboxylation (Scheme 3). The analytical and spectral data of compound 13
are in agreement with the proposed structure (Tables I and II). Thus, the IR spectrum of
compound 13 showed an NH stretching at n 3334 cm–1. Moreover, the 1H NMR spec-
trum revealed the presence of two singlets at d 0.75 and 0.92 ppm corresponding to the
two CH3 groups at C-18, C19, a singlet at d 4.97 ppm for pyrazol H-4, a multiplet at d
5.23 ppm for pyrol H-2, H-3 and a siglet at d 9.11 ppmcorresponding to the NH group.
The reaction of progesterone (1) with cyanoacetic acid hydrazide, in refluxing
1,4-dioxane gave the cyanoacetylhydrazonopregnene derivative 14. The condensation of
C=O group of progesterone (1) with the hydrazide to give hydrazone proceeds in paral-
lel with another reaction recently reported by our group (11) (Scheme 4). The IR spec-
trum of the latter product showed a CN stretching at n 2225 cm–1 and two C=O groups
stretching at n 1718 and 1715 cm–1. Moreover, the 1H NMR showed the presence of a sin-
glet at d 2.11 ppm for the CH2 group (D2O-exchangeable), a singlet at d 9.55 ppm for a
NH group. The MS spectrum of 14 showed m/z = 395 (M+).
Compound 14 reacted with benzaldehyde to give the benzal derivative 15. The reac-
tion of 14 with ethyl cyanoacetate gave 17. Formation of the latter product took place via
the intermediate formation of 16. On the other hand, compound 14 reacted with acetyl-
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acetone to give the oxopyridinyl pregnene derivative 18 (Scheme 4). The reaction of
compound 14 with thioglycolic acid gave the thiazolyl pregnene derivative 19 (12). The
structure of the latter compound was based on analytical and spectral data (Tables I and
II). Thus, the IR spectrum showed an NH stretching at n 3325 cm–1 beside three C=O
groups stretching at n 1718, 1710 and 1695 cm–1 and the 1H NMR spectrum of 19 which
showed two singlets at d 0.78, 0.95 ppm for the two CH3 groups, a singlet at d 4.93 for
the CH2, a singlet at d 5.72 ppm for the thiophene H-2 and a singlet at d 8.25 ppm corres-
ponding to the NH group. The MS spectrum of 19 showed m/z = 469 (M+). On the other
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Shema 4
hand, the reaction of 14 with salicylaldehyde gave the coumarin derivative 20 (Scheme
4). Formation of coumarin via the reaction of salicylaldehyde with cyanomethylene rea-
gents has been reported in literature (13, 14) where the condensation of salicylaldehyde
with the active methylelene of the cyanomethylene reagent to form the corresponding
non isolable arylidene was followed by cyclization and ammonia liberation to give the
isolable coumarin product.
From Table III, it is obvious that no compound showed activity against Pseudomonas
aeruginosa starting from DMSO solutions of 1000 g mL–1 of each compound. Com-
pounds 2 (dimethylaminoacryloyl pregnenone), 11 (17-(3-cyanomethylpyridazin-6-yl)-
androst-4-en-3-one and 15 20-(1-phenyl-2-cyanopropenoylhydrazono)pregn-4-en-3-
-one were active against Escherichia coli only. The results in Table III also clearly revealed
that all tested compounds in the present study, except for compounds 11 and 19 20-(4-
oxothiazol-2-acetylhydrazonyl-2-yl)pregn-4-en-3-one, were active against Gram positi-
ve bacteria. However, compound 19 showed the least activity of the tested compounds.
Compounds 2, 11, 15 are even more potent than the reference drug, ampicillin. Also,
compounds 2, 3a 17-(pyrazol-3-yl)androst-4-en-3-one, 3b 17-(1-phenylpyrazol-3-yl)-
androst-4-en–3-one, 6b 17-(2-hydroxy-3-cyanopyran-6-yl)androst-4-en–3-one, 7 21-
(dimethylaminoacryloyl)-20-(ethylacetoacetato)pregn-4-en-3-one, 9, 11 and 15 are the
most active compound against Candida albicans. Pyranylandrostenone derivative 9 6b
17-(2-hydroxy-3-acetylpyran-6-yl)androst-4-en–3-one showed the maximum activity
against C. albicans. Compounds 7 (with acetyl and ethyl ester groups) and 15 showed ac-
tivity against C. albicans very close to that of the reference cycloheximide and higher
than compounds 19 and 20 20-(coumarin-3-carbohydrazonyl)pregn-4-en-3-one. Com-
pounds 2, 6b, 11, 13, 19 and 20 showed lower activity against B. subtilis than the referen-
ce ampicillin. One can notice the difference between the structures of compounds 2 and
7; condensing the C=O group in 2 with the acetyl and ethyl ester methino groups to pro-
duce compound 7 increases the activity of 7 against Candida albicans. The coumarin deri-
vative 20 showed higher activity towards E. coli than the thiazole derivative 19.
CONCLUSIONS
The structure activity relationship suggested that heterocyclization reactions for
enamine derivative of progesterone into pyrazole, isoxazole, pyrol, thiazole and couma-
rin derivatives resulted in products with high antibacterial and antifungal activity. The-
se findings encourage us to explore new molecules by introducing potent moieties, like
heterocyclic ring systems described in this work, into other hormones. Our prediction is
that these compounds with new ring systems may show even better antimicrobial activity.
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S A @ E T A K
Sinteza heterocikli~kih derivata progesterona s antimikrobnim djelovanjem
RAFAT M. MOHAREB i HANAA Y. HANA
U radu je opisana sinteza steroidnih heterocikli~kih spojeva i evaluacija njihovog
antimikrobnog djelovanja. Sintetizirani spojevi sadr`e pirazol, izoksazol, tiazol, piran,
piridin, piridazin ili benzopiran na pregnenskoj jezgri. Progesteron (1) je prvo u reakciji
s dimetil formamid dimetil acetalom dao enamin 2. Novi steroidni heterocikli~ki deriva-
ti dobiveni su heterociklizacijom spoja 2 s hidrazinima, hidroksilaminom, glicinom, etil-
acetoaceatom i cijanometilenom. Antimikrobno vrednovanje in vitro pokazalo je da su
svi sintetizirani spojevi aktivni protiv testiranih Gram pozitivnih bakterija i gljivica.
Klju~ne rije~i: progesteron, enamin, pirazol, piran, antimikrobno sredstvo
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